STATE STREET CORP - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$54,446,000
+41.3%
2,886,854
-11.8%
0.00%
+33.3%
Q2 2019$38,523,000
-10.8%
3,272,990
+3.4%
0.00%0.0%
Q1 2019$43,209,000
+49.0%
3,165,522
+11.9%
0.00%0.0%
Q4 2018$29,009,000
-44.0%
2,830,135
-9.0%
0.00%
-25.0%
Q3 2018$51,803,000
-1.6%
3,111,338
-6.6%
0.00%0.0%
Q2 2018$52,630,000
-3.5%
3,331,252
-22.5%
0.00%
-20.0%
Q1 2018$54,559,000
+47.6%
4,296,297
+33.0%
0.01%
+66.7%
Q4 2017$36,971,000
-18.5%
3,229,239
-12.8%
0.00%
-25.0%
Q3 2017$45,370,000
+103.8%
3,703,389
+90.4%
0.00%
+100.0%
Q2 2017$22,267,000
-39.8%
1,944,755
+9.4%
0.00%
-33.3%
Q1 2017$36,966,000
+1.1%
1,777,113
+1.0%
0.00%0.0%
Q4 2016$36,579,000
-25.1%
1,758,687
+18.0%
0.00%
-40.0%
Q3 2016$48,843,000
+51.5%
1,490,500
+15.4%
0.01%
+66.7%
Q2 2016$32,237,000
+10.1%
1,291,370
+8.0%
0.00%0.0%
Q1 2016$29,282,000
-10.9%
1,195,800
+20.2%
0.00%
-25.0%
Q4 2015$32,876,000
+14.5%
995,234
+0.0%
0.00%
+33.3%
Q1 2015$28,718,000
+875.8%
994,985
+884.5%
0.00%
Q4 2014$2,943,000
+145.5%
101,062
+6.8%
0.00%
Q3 2014$1,199,000
-10.9%
94,668
+41.1%
0.00%
Q2 2014$1,345,00067,1110.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 2,942,130$37,365,0008.14%
Foresite Capital Management II, LLC 1,686,220$21,415,0007.12%
Foresite Capital Management IV, LLC 830,919$10,553,0004.38%
SENZAR ASSET MANAGEMENT, LLC 822,890$10,451,0003.30%
Redmile Group, LLC 6,505,766$82,623,0003.19%
DAFNA Capital Management LLC 396,013$5,029,0002.45%
SECTORAL ASSET MANAGEMENT INC 863,600$10,968,0001.20%
Palo Alto Investors LP 1,849,832$23,493,0001.00%
Bellevue Group AG 700,464$8,896,0000.88%
Rock Springs Capital Management LP 1,529,800$19,428,0000.83%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders